Clinical trial
Ketoconazole With or Without Alendronate Sodium in Treating Patients With…
NCT00019695 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00019695 |
|---|---|
| Title | Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer |
| Official title | Phase II Randomized Study of High-Dose Ketoconazole With or Without Alendronate Sodium in Patients With Androgen-Independent Metastastic Adenocarinoma of the Prostate |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stage IV Prostate Cancer, Bone Metastases, Adenocarcinoma of the Prostate, Recurrent Prostate Cancer |
| Intervention type | Drug |
| Interventions | alendronate sodium, ketoconazole |
| Start date | Mar 1, 1999 |
| Completion | Mar 1, 2005 |
| First posted | Mar 5, 2007 |
| Last update posted | Mar 4, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: